Bullish option flow detected in Mineralys Therapeutics (MLYS) Inc with 1,300 calls trading, 3x expected, and implied vol increasing almost 6 points to 90.78%. Jun-26 35 calls and Mar-26 40 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.05. Earnings are expected on February 12th.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
- Mineralys Therapeutics: Lorundrostat’s Broad Efficacy, Favorable Safety, and Upside Indications Support Buy Rating on MLYS
- Mineralys updates lorundrostat program and upcoming data milestones
- Mineralys Therapeutics provides corporate update
- Mineralys Therapeutics price target raised to $46 from $43 at BofA